A New Dawn in Prevention: How Lecheng Brought a Twice-Yearly HIV Shield to China in Record Time
Lecheng2026-01-21T10:53:48+08:00Lecheng becomes the first in China to offer lenacapavir, a groundbreaking twice-yearly injectable for HIV prevention. Learn about its unique mechanism, advantages over traditional PrEP, and global approvals.











